HealthStream, Inc.
HSTMNASDAQHealthcare● Active
$25.65
+$0.41(+1.62%)
Market Cap$749369880
P/E Ratio—
52W High$29.63
52W Low$19.5
HealthStream, Inc. (HSTM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HSTM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 4, 2026EPS Actual
$0.20
Est. $0.16 · +25.0%
Revenue
$0.08B
Est. $0.08B · +1.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 4, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
HSTM reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | $0.17 | — | — | — | $0.08B | — |
| ▲ Q2 FY2026 | May 4, 2026 | $0.16 | $0.20 | +25.0% | $0.08B | $0.08B | +1.9% |
| ▲ Q1 FY2026 | Feb 23, 2026 | $0.16 | $0.18 | +12.5% | $0.08B | $0.08B | +4.6% |
| ▲ Q4 FY2025 | Nov 3, 2025 | $0.17 | $0.20 | +17.6% | $0.08B | $0.08B | +0.3% |
| ▲ Q3 FY2025 | Aug 4, 2025 | $0.16 | $0.18 | +12.5% | $0.07B | $0.08B | -1.8% |
| ▼ Q2 FY2025 | May 5, 2025 | $0.16 | $0.14 | -12.5% | $0.07B | $0.08B | -2.3% |
| ▲ Q1 FY2025 | Feb 24, 2025 | $0.13 | $0.16 | +23.1% | $0.07B | $0.07B | +0.9% |
| ▲ Q4 FY2024 | Oct 21, 2024 | $0.13 | $0.19 | +46.1% | $0.07B | $0.07B | -0.6% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
$0.17
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 4, 2026Beat
EPS Actual
$0.20
EPS Est.
$0.16
EPS Surpr.
+25.0%
Revenue
$0.08B
Q1 FY2026
Feb 23, 2026Beat
EPS Actual
$0.18
EPS Est.
$0.16
EPS Surpr.
+12.5%
Revenue
$0.08B
Q4 FY2025
Nov 3, 2025Beat
EPS Actual
$0.20
EPS Est.
$0.17
EPS Surpr.
+17.6%
Revenue
$0.08B
Q3 FY2025
Aug 4, 2025Beat
EPS Actual
$0.18
EPS Est.
$0.16
EPS Surpr.
+12.5%
Revenue
$0.07B
Q2 FY2025
May 5, 2025Miss
EPS Actual
$0.14
EPS Est.
$0.16
EPS Surpr.
-12.5%
Revenue
$0.07B
Q1 FY2025
Feb 24, 2025Beat
EPS Actual
$0.16
EPS Est.
$0.13
EPS Surpr.
+23.1%
Revenue
$0.07B
Q4 FY2024
Oct 21, 2024Beat
EPS Actual
$0.19
EPS Est.
$0.13
EPS Surpr.
+46.1%
Revenue
$0.07B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.23 | $0.23 | $0.24 | 1 |
| Q3 FY2027 | $0.21 | $0.21 | $0.22 | 1 |
| Q2 FY2027 | $0.21 | $0.21 | $0.21 | 1 |
| Q1 FY2027 | $0.21 | $0.21 | $0.21 | 1 |
| Q4 FY2026 | $0.19 | $0.19 | $0.19 | 1 |
| Q3 FY2026 | $0.17 | $0.18 | $0.18 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 4, 2026 | +25.0% | $20.72 | $21.25 | +2.56% |
| ▲ Q1 FY2026 | Feb 23, 2026 | +12.5% | $20.35 | $21.24 | +4.37% |
| ▲ Q4 FY2025 | Nov 3, 2025 | +17.6% | $24.60 | $25.32 | +2.93% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +12.5% | $25.65 | $26.05 | +1.56% |
| ▼ Q2 FY2025 | May 5, 2025 | -12.5% | $34.07 | $33.24 | -2.44% |
| ▲ Q1 FY2025 | Feb 24, 2025 | +23.1% | $32.88 | $32.35 | -1.61% |
| ▲ Q4 FY2024 | Oct 21, 2024 | +46.1% | $28.84 | $28.45 | -1.35% |
| ▲ Q3 FY2024 | Jul 22, 2024 | +16.7% | $30.38 | $30.70 | +1.05% |
Q2 FY2026+2.56%
Report Date
May 4, 2026
EPS Beat/Miss
+25.0%
Price Before
$20.72
Price After
$21.25
Q1 FY2026+4.37%
Report Date
Feb 23, 2026
EPS Beat/Miss
+12.5%
Price Before
$20.35
Price After
$21.24
Q4 FY2025+2.93%
Report Date
Nov 3, 2025
EPS Beat/Miss
+17.6%
Price Before
$24.60
Price After
$25.32
Q3 FY2025+1.56%
Report Date
Aug 4, 2025
EPS Beat/Miss
+12.5%
Price Before
$25.65
Price After
$26.05
Q2 FY2025-2.44%
Report Date
May 5, 2025
EPS Beat/Miss
-12.5%
Price Before
$34.07
Price After
$33.24
Q1 FY2025-1.61%
Report Date
Feb 24, 2025
EPS Beat/Miss
+23.1%
Price Before
$32.88
Price After
$32.35
Q4 FY2024-1.35%
Report Date
Oct 21, 2024
EPS Beat/Miss
+46.1%
Price Before
$28.84
Price After
$28.45
Q3 FY2024+1.05%
Report Date
Jul 22, 2024
EPS Beat/Miss
+16.7%
Price Before
$30.38
Price After
$30.70
Avg Beat Reaction+1.36%
Avg Miss Reaction-2.44%
Beat Rate7 / 8 quarters
Largest Move+4.37% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HSTM ends December
HealthStream, Inc. (HSTM) most recently reported earnings on May 4, 2026 for Q2 FY2026, posting EPS of $0.20 — beating the analyst consensus of $0.16 by +25.0%. HSTM has beaten EPS estimates for 4 consecutive quarters. The next HSTM earnings date is expected around September 1, 2026.
Each quarter, investors track HSTM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HSTM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HSTM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HSTM earnings · 5 questionsHealthStream, Inc.'s next earnings report is expected around September 1, 2026. HSTM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HSTM historically reports after market close (AMC).
HSTM earnings datewhen is HSTM earningsHSTM next earnings datewhen does HSTM report earningsHSTM earnings calendar
▸ Source: FMP · HealthStream, Inc. SEC filings · US GAAP · HealthStream, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026